Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Mallinckrodt
Harvard Business School
Medtronic
McKinsey

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Patent: 10,065,934

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 10,065,934
Title:Substituted urea derivatives and pharmaceutical uses thereof
Abstract: Provided herein are novel substituted urea derivatives, and pharmaceutical compositions thereof. Also provided herein are uses of the compounds or pharmaceutical compositions thereof for preventing, managing, treating or lessening a proliferative disease, and modulating the activity of protein kinase.
Inventor(s): Cheng; Changchung (Dongguan, CN), Zhang; Yingjun (Dongguan, CN), Liu; Bing (Dongguan, CN), Long; Bohua (Dongguan, CN), Chen; Yu (Dongguan, CN), Cheng; Zhixin (Dongguan, CN)
Assignee: SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)
Application Number:15/314,938
Patent Claims:see list of patent claims

Details for Patent 10,065,934

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-07-17 RX search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-07-17 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-07-17 RX Orphan search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125399 001 2011-08-19   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-07-17 RX search
Seattle Genetics ADCETRIS brentuximab vedotin INJECTABLE; INJECTION 125388 001 2011-08-19   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-07-17 RX Orphan search
Bristol Myers Squibb YERVOY ipilimumab INJECTABLE; INJECTION 125377 001 2011-03-25   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-07-17 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.